Overview
MUSC Hollings Cancer Center leadership anticipates distributing two awards of $50,000 per year for one year with the possibility of no cost extensions for up to one year. Extensions will require prior approval. One award will support a partnership between Cancer Prevention & Control and Cancer Biology & Immunology. One award will support a partnership between Cancer Prevention & Control and Developmental Cancer Therapeutics.
Sources of funding for the award include the Hollings Cancer Center Support Grant (P30 CA138313), fundraising from the LOWVELO bike ride, or other Hollings philanthropy/foundation accounts. PIs are expected to obtain regulatory approvals (e.g., IACUC and IRB) within three months of award decision. Please note that the funding cannot be released until required approvals have been obtained for any human and animal subject protocols and copies have been provided. For more information or questions regarding the Hollings Bridge to Population Science Award, eligibility, or the application process, please contact Renee Steffen (steffenr@musc.edu).
Eligibility
- Proposed research must be cancer relevant.
- Must be a Hollings member (full or affiliate).
- At least one member of Cancer Prevention & Control and at least one member of either Cancer Biology & Immunology or Developmental Cancer Therapeutics, who will serve in Co-PI roles.
- Applicants that demonstrate a new collaboration will be prioritized.
- Applicants must make use of at least one of the seven Hollings shared resources.
- Applicants are encouraged but not required to include partnerships with South Carolina State University.
- All awarded PIs are encouraged to participate as a registered rider in the annual LOWVELO bike ride.
Evaluation
- Priority will be given to early stage investigators.
- Review criteria include:
- Standard NIH criteria
- Potential to lead to future NIH funding
